In an interim order, the Delhi High Court on Tuesday directed that no coercive steps be taken against the sale of 328 fixed-dose combination (FDC) drugs that were banned by the government last week but are still available in the market.

The order came on pleas filed by different pharma companies to challenge a Ministry of Health and Family Welfare decision to ban the manufacture, sale and distribution of these FDC drugs with immediate effect.